Chemical Formula: C19H32O2

Chemical Formula C19H32O2

Found 106 metabolite its formula value is C19H32O2

3b,17b-Dihydroxyetiocholane

(2S,5S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


The unspecified form of the steroid, normally a major metabolite of testosterone with androgenic activity. It has been implicated as a regulator of gonadotropin secretion. [HMDB] The unspecified form of the steroid, normally a major metabolite of testosterone with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.

   

16alpha-Hydroxysteroid

10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol

C19H32O2 (292.24021719999996)


   

Steroid hydroperoxide

3-hydroperoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

C19H32O2 (292.24021719999996)


   

Grevillol

5-tridecylbenzene-1,3-diol

C19H32O2 (292.24021719999996)


   

NCIOpen2_002289

D-Homo-17a-oxa-5alpha-androstan-3beta-ol

C19H32O2 (292.24021719999996)


   

MCULE-3958492202

5alpha-Androstane-11beta,17beta-diol

C19H32O2 (292.24021719999996)


   

3a,17a-Dihydroxy-5b-androstane

(2S,5R,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


The unspecified form of the steroid, normally a major metabolite of testosterone with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.;3a,17a-Dihydroxy-5b-androstane is a metabolite of natural androgens (testosterone, epitestosterone, dihydrotestosterone, and dehydroepiandrosterone) present in small amount in the urine of normal individuals (PMID 9381514) [HMDB] The unspecified form of the steroid, normally a major metabolite of testosterone with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.3a,17a-Dihydroxy-5b-androstane is a metabolite of natural androgens (testosterone, epitestosterone, dihydrotestosterone, and dehydroepiandrosterone) present in small amount in the urine of normal individuals (PMID 9381514). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

5alpha-Androstane-3beta,17beta-diol

(1S,2S,5S,7S,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


Androstane-3,17-diol is a metabolite of dihydrotestosterone. It doesnt bind androgen receptors, but efficiently binds the estrogen receptor beta and inhibits prostate cancer cell migration through the activation of estrogen receptor beta. (PMID 15958594) [HMDB] Androstane-3,17-diol is a metabolite of dihydrotestosterone. It doesnt bind androgen receptors, but efficiently binds the estrogen receptor beta and inhibits prostate cancer cell migration through the activation of estrogen receptor beta (PMID: 15958594).

   

Hydroxysteroid

2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,13-diol

C19H32O2 (292.24021719999996)


   

5a-Androstane-3a,17b-diol

5alpha-Androstane-3alpha,17beta-diol

C19H32O2 (292.24021719999996)


The 5alpha-stereoisomer of androstane-3alpha,17beta-diol.

   
   

5alpha-androstan-3alpha,17alpha-diol monosulfate

(1S,2S,5S,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


3beta,17alpha-Dihydroxy-5alpha-androstane is a steroid found in the monosulfate fraction of normal human feces. Several steroids identified in the disulfate fraction of human bile are found in the monosulfate fraction of human feces, indicating partial hydrolysis of diconjugates in the intestine. The androstanediols and pregnanediols found in the feces are primarily of a 3beta-hydroxy-5alpha- or 3beta-hydroxy-5beta-structure, whereas those in the bile are of a 3alpha-hydroxy-5alpha- or 3alpha-hydroxy-5beta-structure. This suggests the conversion of a 3alpha-hydroxyl to a 3beta-hydroxyl in the intestine in vivo. 3beta,17alpha-Dihydroxy-5alpha-androstane is also found unconjugated in normal human plasma (PMID: 4245755, 4223807, 4321841, 1769135). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents

   

5alpha-Androstane-3alpha,17alpha-diol

(1S,2S,5R,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


5alpha-Androstane-3alpha,17a-diol belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favour the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. 5alpha-Androstane-3alpha,17a-diol is a steroid found in feces from pregnant women (PMID: 5440628), the monosulfate and disulfate fractions from normal human feces (PMID: 4245755), and the glucuronide and mono- and disulphate conjugates of neutral steroids in human bile (PMID: 5493463). 5a-Androstane-3a,17a-diol is an steroid found in feces from pregnant women (PMID 5440628), primarily in the monosulfate and disulfate fractions from normal human (PMID 4245755), and glucuronide and mono- and disulphate conjugates of neutral steroids in human bile (PMID 5493463) [HMDB]

   

Androstanediol

(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The eicosapentaenoic acid moiety is derived from fish oils, liver and kidney, while the docosapentaenoic acid moiety is derived from animal fats and brain. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Androstanediol is a metabolite of dihydrotestosterone, itself a metabolite of testosterone. Androstanediol is implicated in the regulation of gonadotropin secretion. As a metabolite of dihydroxytestosterone formed in the peripheral tissues, androstanediol and androstnediol-glucuronide can be used to estimate peripheral androgen activity. Androstanediol is a potential GABA (A) receptor-modulating neurosteroid with anticonvulsant properties and hence could act as a key neuromodulator in the central nervous system. It is considered that androstanediol has hedonic effects; therefore it is anticipated that androgens that are readily metabolized to androstanediol may have higher abuse potential than androgens that are not as easily metabolized to androstanediol. These results add to the growing literature indicating that athletes and non-athletes may be at considerable risk when they abuse androgens. (PMID: 11500254, 16040068, 11744084).

   

Etiocholanediol

(1S,2S,5R,7R,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


Etiocholanediol is one of the compounds tested to allow for the unequivocal identification of the presence of urinary anabolic steroids and metabolites banned for use in sport by athletes. In urine samples collected for anti-doping purposes with moderately elevated testosterone and epitestosterone ratio, or when a suspicion of manipulation of the sample occurs, Etiocholanediol is tested for further clarification. It is worth mentioning that the concentration parameters vary enormously according to the gender of the subjects, ethnic origin, the urine collection period (before or after effort, period of the day) and the hydration state of the athlete. Urinary steroid data using several methodologies are not appropriate for identification purposes and to an extent not unique to individuals. (PMID: 16337352, 16338181, 16337352, 17260133) [HMDB] Etiocholanediol is one of the compounds tested to allow for the unequivocal identification of the presence of urinary anabolic steroids and metabolites banned for use in sport by athletes. In urine samples collected for anti-doping purposes with moderately elevated testosterone and epitestosterone ratio, or when a suspicion of manipulation of the sample occurs, Etiocholanediol is tested for further clarification. It is worth mentioning that the concentration parameters vary enormously according to the gender of the subjects, ethnic origin, the urine collection period (before or after effort, period of the day) and the hydration state of the athlete. Urinary steroid data using several methodologies are not appropriate for identification purposes and to an extent not unique to individuals. (PMID: 16337352, 16338181, 16337352, 17260133).

   

Dihydroandrosterone

(1S,2S,5R,7S,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


Dihydroandrosterone is a major metabolite of testosterone. Dihydroandrosterone is the main steroid produced by the immature ovary; at puberty the synthesis of steroids shifts toward 4-ene-3-oxo steroids. testosterone 5a-reduced metabolites, including dihydrotestosterone are produced in the anterior pituitary and the central nervous system. Anabolic androgen steroid (AAS) are one of primary performance-enhancing substances abused by athletes. To defeat doping controls, athletes changed to take endogenous androgens from the application of synthetic AAS. testosterone was one candidate of endogenous androgens abused in sports. testosterone and its relevant steroids in urine is detected and monitored with GC/MS. The abuse of anabolic-androgenic steroids (AS) is a growing problem; however, the effects and mechanisms underlying their addictive effects are not well understood. (PMID: 17112575, 6243214, 491593, 491592) [HMDB] Dihydroandrosterone is a major metabolite of testosterone. Dihydroandrosterone is the main steroid produced by the immature ovary; at puberty the synthesis of steroids shifts toward 4-ene-3-oxo steroids. testosterone 5a-reduced metabolites, including dihydrotestosterone are produced in the anterior pituitary and the central nervous system. Anabolic androgen steroid (AAS) are one of primary performance-enhancing substances abused by athletes. To defeat doping controls, athletes changed to take endogenous androgens from the application of synthetic AAS. testosterone was one candidate of endogenous androgens abused in sports. testosterone and its relevant steroids in urine is detected and monitored with GC/MS. The abuse of anabolic-androgenic steroids (AS) is a growing problem; however, the effects and mechanisms underlying their addictive effects are not well understood. (PMID: 17112575, 6243214, 491593, 491592).

   

Androstan-3alpha,17beta-diol

(5R,14S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-diol

C19H32O2 (292.24021719999996)


This compound belongs to the family of Androgens and Derivatives. These are hydroxylated C19 steroid hormones. They are known to favour the development of masculine characteristics. They also show profound effects on scalp and body hair in humans.

   

(17S)-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

(17S)-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

C19H32O2 (292.24021719999996)


   

Methyl linolenate

Methyl octadeca-9,12,15-trienoic acid

C19H32O2 (292.24021719999996)


   
   
   
   

18-Nor-8(17),13E-labdadiene-4alpha,15-diol

18-Nor-8(17),13E-labdadiene-4alpha,15-diol

C19H32O2 (292.24021719999996)


   

Methyl linolenate

Methyl linolenate

C19H32O2 (292.24021719999996)


Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters. Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters.

   

Pinolenic Acid methyl ester

5Z,9Z,12Z-octadecatrienoic acid, methyl ester

C19H32O2 (292.24021719999996)


   

9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester

9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester

C19H32O2 (292.24021719999996)


   

Me ester-(2E,9Z,12Z)-2,9,12-Octadecatrienoic acid

Me ester-(2E,9Z,12Z)-2,9,12-Octadecatrienoic acid

C19H32O2 (292.24021719999996)


   
   
   

trans-3-cis-12-octadecadiensaeure

trans-3-cis-12-octadecadiensaeure

C19H32O2 (292.24021719999996)


   

(12E)-8-hydroxy-15-nor-12-labden-14-al|15-nor-8-hydroxy-12E-labdan-14-al

(12E)-8-hydroxy-15-nor-12-labden-14-al|15-nor-8-hydroxy-12E-labdan-14-al

C19H32O2 (292.24021719999996)


   

methyl octadeca-9,12,15-trienoate

methyl octadeca-9,12,15-trienoate

C19H32O2 (292.24021719999996)


   

ent-6alpha,8alpha-dihydroxylabda-13(16),14-diene

ent-6alpha,8alpha-dihydroxylabda-13(16),14-diene

C19H32O2 (292.24021719999996)


   
   

12-methyloctadeca-17-ene-5-ynoic acid

12-methyloctadeca-17-ene-5-ynoic acid

C19H32O2 (292.24021719999996)


   

4beta-hydroxy-19-normanoyl oxide

4beta-hydroxy-19-normanoyl oxide

C19H32O2 (292.24021719999996)


   
   

methyl octadec-5,6,16-trienoate

methyl octadec-5,6,16-trienoate

C19H32O2 (292.24021719999996)


   

8alpha,15-epoxy-16-norlabdan-13-one

8alpha,15-epoxy-16-norlabdan-13-one

C19H32O2 (292.24021719999996)


   

methyl octadeca-6,9,12-trienoate

methyl octadeca-6,9,12-trienoate

C19H32O2 (292.24021719999996)


   

cis-Octadec-9-en-12-in-1-saeuremethylester|cis-Octadecen-(9)-in-(12)-saeuremethylester, Crepenynsaeuremethylester|Crepeninsaeuremethylester (Methyl Crepenynate)|methyl cis-octadec-9-en-12-ynoate|methyl crepenynate|Methyl-cis-9-octadecen-12-inoat (Crepeninsaeuremethylester)|Octadeca-9c-en-12-in-carbonsaeuremethylester

cis-Octadec-9-en-12-in-1-saeuremethylester|cis-Octadecen-(9)-in-(12)-saeuremethylester, Crepenynsaeuremethylester|Crepeninsaeuremethylester (Methyl Crepenynate)|methyl cis-octadec-9-en-12-ynoate|methyl crepenynate|Methyl-cis-9-octadecen-12-inoat (Crepeninsaeuremethylester)|Octadeca-9c-en-12-in-carbonsaeuremethylester

C19H32O2 (292.24021719999996)


   

E-11-octadecen-9-ynoic acid methyl ester|methyl 11-trans-octadecen-9-ynoate|methyl santalbate|methyl trans-octadec-11-en-9-ynoate|octadec-11t-en-9-ynoic acid methyl ester|trans-ximenynic acid methyl ester|ximenynic acid methyl ester

E-11-octadecen-9-ynoic acid methyl ester|methyl 11-trans-octadecen-9-ynoate|methyl santalbate|methyl trans-octadec-11-en-9-ynoate|octadec-11t-en-9-ynoic acid methyl ester|trans-ximenynic acid methyl ester|ximenynic acid methyl ester

C19H32O2 (292.24021719999996)


   
   

18-Norlabda-8(17),14-dien-4alpha,13beta-diol

18-Norlabda-8(17),14-dien-4alpha,13beta-diol

C19H32O2 (292.24021719999996)


   

19-Noranticopalsaeure-methylester

19-Noranticopalsaeure-methylester

C19H32O2 (292.24021719999996)


   

ent-8alpha,18-dihydroxylabda-13(16),14-diene

ent-8alpha,18-dihydroxylabda-13(16),14-diene

C19H32O2 (292.24021719999996)


   
   

Junicedral, Labd-8(17)-en-15,19-dial

Junicedral, Labd-8(17)-en-15,19-dial

C19H32O2 (292.24021719999996)


   
   

Methyl-17-octadecen-9-inoat|Octadec-17-en-9-insaeure-methylester

Methyl-17-octadecen-9-inoat|Octadec-17-en-9-insaeure-methylester

C19H32O2 (292.24021719999996)


   
   

9-octadecen-6-ynoic acid methyl ester

9-octadecen-6-ynoic acid methyl ester

C19H32O2 (292.24021719999996)


   

(3Z,6R,7S,9R,10S)-6,7:9,10-bisepoxynonadeca-3,18-diene

(3Z,6R,7S,9R,10S)-6,7:9,10-bisepoxynonadeca-3,18-diene

C19H32O2 (292.24021719999996)


   
   

Methyllinolenate

Methyl linolenate, United States Pharmacopeia (USP) Reference Standard

C19H32O2 (292.24021719999996)


Methyl linolenate is a fatty acid methyl ester derived from alpha-linolenic acid. It has a role as a plant metabolite and an insect attractant. It is functionally related to an alpha-linolenic acid. Methyl linolenate is a natural product found in Hedysarum polybotrys, Azadirachta indica, and other organisms with data available. A fatty acid methyl ester derived from alpha-linolenic acid. Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters. Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters.

   

ETIOCHOLANDIOL

5-beta-Androstane-3-alpha,17-beta-diol

C19H32O2 (292.24021719999996)


Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

C19H32O2_14-(Hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecan-5-ol

NCGC00384837-01_C19H32O2_14-(Hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecan-5-ol

C19H32O2 (292.24021719999996)


   

5α-Androstane-3β,17β-diol

5alpha-Androstane-3beta,17beta-diol

C19H32O2 (292.24021719999996)


An androstane-3,17-diol that is 5alpha-androstane substituted by beta-hydroxy groups at positions 3 and 17. It is a metabolite of dihydrotestosterone.

   

Androstane-3,17-diol

Androstane-3,17-diol

C19H32O2 (292.24021719999996)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents

   

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol

C19H32O2 (292.24021719999996)


   

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol_major

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol_major

C19H32O2 (292.24021719999996)


   

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol_95.7\\%

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-ol_95.7\\%

C19H32O2 (292.24021719999996)


   

8-hydroxy-11E-octadecen-9-ynoic acid

8-hydroxy-11E-octadecen-9-ynoic acid

C19H32O2 (292.24021719999996)


   
   

Methyl γ-linolenate

6Z,9Z,12Z-octadecatrienoic acid, methyl ester

C19H32O2 (292.24021719999996)


A fatty acid methyl ester obtained from the formal condensation of methanol and gamma-linolenic acid.

   

9Z,11E,13E-octadecatrienoic acid, methyl ester

9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester

C19H32O2 (292.24021719999996)


   

3b,17b-Dihydroxyetiocholane

5beta-androstane-3beta,17beta-diol

C19H32O2 (292.24021719999996)


   
   
   

Hombreol

(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

C19H32O2 (292.24021719999996)


   

5beta-androstane-3beta,17beta-diol

(3beta,5beta,17beta)-androstane-3,17-diol

C19H32O2 (292.24021719999996)


   

Acetylenic acids

11-Octadecen-9-ynoic acid, 8-hydroxy-, (E)-

C19H32O2 (292.24021719999996)


   

WE(12:3(2E,6E,10E)(3Me,7Me,11Me)/4:0)

(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl butyrate

C19H32O2 (292.24021719999996)


   

14-(Hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecan-5-ol

14-(Hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecan-5-ol

C19H32O2 (292.24021719999996)


   

FA 19:3

16-methyl-octadeca-5,9,12-trienoic acid, (Z,Z,Z)-

C19H32O2 (292.24021719999996)


   

SFE 19:3

(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl butyrate

C19H32O2 (292.24021719999996)


   

ST 19:0;O2

(3alpha,5beta,17beta)-androstane-3,17-diol

C19H32O2 (292.24021719999996)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents

   

2,5-bis(1,1-dimethylbutyl)-4-methoxyphenol

2,5-bis(1,1-dimethylbutyl)-4-methoxyphenol

C19H32O2 (292.24021719999996)


   

CGP 7930

2,6-Ditert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol

C19H32O2 (292.24021719999996)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists

   

Propanoic acid,2-methyl-, 1-ethenyl-1,5,9-trimethyl-4,8-decadien-1-yl ester

Propanoic acid,2-methyl-, 1-ethenyl-1,5,9-trimethyl-4,8-decadien-1-yl ester

C19H32O2 (292.24021719999996)


   

(12E)-15-Nor-8-hydroxy-12-labden-14-al

(12E)-15-Nor-8-hydroxy-12-labden-14-al

C19H32O2 (292.24021719999996)


   

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

C19H32O2 (292.24021719999996)


   
   

D-Homo-17a-oxa-5alpha-androstan-3beta-ol

D-Homo-17a-oxa-5alpha-androstan-3beta-ol

C19H32O2 (292.24021719999996)


   

5alpha-Androstane-11beta,17beta-diol

5alpha-Androstane-11beta,17beta-diol

C19H32O2 (292.24021719999996)


   

AI3-26935

9,12,15-Octadecatrienoic acid, methyl ester, (9Z,12Z,15Z)-

C19H32O2 (292.24021719999996)


Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters. Methyl linolenate prevents the oxidation or pre-oxidation of unsaturated fatty acid methyl esters.

   
   
   
   
   

(3R,5R,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

(3R,5R,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

C19H32O2 (292.24021719999996)


   

(5Z,8Z,11Z)-nonadeca-5,8,11-trienoic acid

(5Z,8Z,11Z)-nonadeca-5,8,11-trienoic acid

C19H32O2 (292.24021719999996)


   
   

(7E,11E)-1-(2-Hydroxyethyl)-2,3-epoxy-1,7,11-trimethylcyclotetradecadiene

(7E,11E)-1-(2-Hydroxyethyl)-2,3-epoxy-1,7,11-trimethylcyclotetradecadiene

C19H32O2 (292.24021719999996)


   
   

(Z,Z,Z)-6,12,15-Octadecatrienoic acid methyl ester

(Z,Z,Z)-6,12,15-Octadecatrienoic acid methyl ester

C19H32O2 (292.24021719999996)


   

(Z,Z,Z)-6,9,15-Octadecatrienoic acid methyl ester

(Z,Z,Z)-6,9,15-Octadecatrienoic acid methyl ester

C19H32O2 (292.24021719999996)


   

(10E,13E,16E)-nonadeca-10,13,16-trienoic acid

(10E,13E,16E)-nonadeca-10,13,16-trienoic acid

C19H32O2 (292.24021719999996)


   

2-[(5E,9Z)-2,6,10-trimethyl-15-oxabicyclo[12.1.0]pentadeca-5,9-dien-2-yl]ethanol

2-[(5E,9Z)-2,6,10-trimethyl-15-oxabicyclo[12.1.0]pentadeca-5,9-dien-2-yl]ethanol

C19H32O2 (292.24021719999996)


   

3-hydroperoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

3-hydroperoxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

C19H32O2 (292.24021719999996)


   

5alpha-androstane-3beta,17alpha-diol

5alpha-androstane-3beta,17alpha-diol

C19H32O2 (292.24021719999996)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents

   

16-methyl-octadeca-5Z,9Z,12Z-trienoic acid

16-methyl-octadeca-5Z,9Z,12Z-trienoic acid

C19H32O2 (292.24021719999996)